Form D · Other

NEKCOM INC.

Wuhan, F4 · CIK 0002049792

Offering snapshot reported Dec 31, 2024 · SEC filing

Reported sold
$15M
Offering amount: $15M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 18, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 31, 2024Initial$15,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$675K
Finders' fees
$0
Form D file number
021-533739

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Dongsheng Shenzhou Biotechnology (Xiamen) Co., Ltd.None

Source: Form D, filed Dec 31, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Xiaoyun Dong Promoter
Jixuan Fang Promoter
Yan Huang Promoter
Dongning Li Director, Promoter
Xiangyu Luo Director, Executive, Promoter
Guangzhi Ma Promoter
Ryan You Director

Issuer details

Industry: Other (See others in industry)

Address:
Floor 1 2,Bldg 20,National Lighting Cube Wuhan East Lake Hi Tech Development Zone
Wuhan, F4, 430000